Literature DB >> 21694455

Dementia-associated mortality at thirteen years in the NEDICES Cohort Study.

Alberto Villarejo1, Julián Benito-León, Rocío Trincado, Ignacio J Posada, Verónica Puertas-Martín, Raquel Boix, M Rm A José Medrano, Félix Bermejo-Pareja.   

Abstract

To evaluate the mortality, thirteen years after the baseline wave (1994), of participants suffering dementia in the Neurological Disorders in Central Spain (NEDICES) Cohort Study, we conducted a population-based cohort study in the elderly (65 years and more) with 5,278 screened participants at baseline. Mortality has been evaluated by means of the National Death Registry of Spain at 1-5-2007, 13 years after enrolment. Cox's proportional hazards regression models were used to evaluate the hazard of death according to dementia severity and type, adjusting for potential covariates (gender, age, level of education, and co-morbidity). Survival was estimated using Kaplan-Meier method. Of the 5,278 participants screened at baseline, 306 had dementia. Mortality at 13 years was: 275 deaths (89.9%) in dementia subjects; and 2,426 (49.0%) in subjects without dementia. Mortality was higher and statistically significant in dementia subjects. The degree of dementia (DSM-III-R) correlated with the risk of mortality, from mild (HR = 2.23; CI: 1.77-2.82) to moderate (HR =3.10; CI: 2.47-3.89) and severe dementia (HR = 4.98; CI: 3.85-6.44). Survival was similar in Alzheimer's disease and vascular dementia. Factors associated with higher mortality in Cox proportional hazard models were older age, male gender, and comorbidity. Using Population Attributable risk (PAR%), dementia was related to 11.3% of all deaths. Dementia intensity increases the mortality risk at ten years in the NEDICES Study as in other cohort studies. Age, gender, and co-morbidity are associated with higher mortality in dementia patients. Almost one third of deaths in persons over 85 years-old could be attributable to dementia.

Entities:  

Mesh:

Year:  2011        PMID: 21694455     DOI: 10.3233/JAD-2011-110443

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  27 in total

1.  Co-occurrence of parkinsonism and dementia in clinical practice: relevant differential diagnoses.

Authors:  I Liepelt-Scarfone; M Jamour; W Maetzler
Journal:  Z Gerontol Geriatr       Date:  2012-01       Impact factor: 1.281

2.  Body mass index, weight change, and clinical progression in mild cognitive impairment and Alzheimer disease.

Authors:  Lilah M Besser; Dawn P Gill; Sarah E Monsell; Willa Brenowitz; Dana H Meranus; Walter Kukull; Deborah R Gustafson
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jan-Mar       Impact factor: 2.703

3.  Cause of death in mild cognitive impairment: a prospective study (NEDICES).

Authors:  I Contador; F Bermejo-Pareja; A J Mitchell; R Trincado; A Villarejo; Á Sánchez-Ferro; J Benito-León
Journal:  Eur J Neurol       Date:  2013-10-15       Impact factor: 6.089

4.  Long sleep duration in elders without dementia increases risk of dementia mortality (NEDICES).

Authors:  Julián Benito-León; Elan D Louis; Alberto Villarejo-Galende; Juan P Romero; Félix Bermejo-Pareja
Journal:  Neurology       Date:  2014-09-24       Impact factor: 9.910

5.  Faster cognitive decline in elders without dementia and decreased risk of cancer mortality: NEDICES Study.

Authors:  Julián Benito-León; Juan Pablo Romero; Elan D Louis; Félix Bermejo-Pareja
Journal:  Neurology       Date:  2014-04-09       Impact factor: 9.910

6.  Malnutrition, functional ability and mortality among older people aged ⩾ 60 years: a 7-year longitudinal study.

Authors:  M Naseer; H Forssell; C Fagerström
Journal:  Eur J Clin Nutr       Date:  2015-11-25       Impact factor: 4.016

7.  Dementia remains the major predictor of death among octogenarians. A study of two population cohorts of 85-year-olds examined 22 years apart.

Authors:  Hanna Wetterberg; Jenna Najar; Lina Rydén; Mats Ribbe; Therese Rydberg Sterner; Anna Zettergren; Xinxin Guo; Hanna Falk Erhag; Simona Sacuiu; Silke Kern; Ingmar Skoog
Journal:  Eur J Epidemiol       Date:  2021-04-21       Impact factor: 8.082

8.  Dementia increases mortality beyond effects of comorbid conditions: A national registry-based cohort study.

Authors:  Laerke Taudorf; Ane Nørgaard; Henry Brodaty; Thomas Munk Laursen; Gunhild Waldemar
Journal:  Eur J Neurol       Date:  2021-05-14       Impact factor: 6.089

9.  Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer's disease.

Authors:  Pierre Tariot; Steven Salloway; Jane Yardley; Joan Mackell; Margaret Moline
Journal:  BMC Res Notes       Date:  2012-06-08

10.  A review of the potential therapeutic role of statins in the treatment of Alzheimer's disease: current research and opinion.

Authors:  Alvaro Sánchez-Ferro; Julián Benito-León; Alex J Mitchell; Félix Bermejo-Pareja
Journal:  Neuropsychiatr Dis Treat       Date:  2013-01-04       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.